A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The purpose of the current study is to evaluate the efficacy and safety of Fremanezumab (TEV-48125), in the prevention of CCH in adult participants.
Epistemonikos ID: fd8829983e18655e90bf982b703b92e3aeb93687
First added on: May 17, 2024